Literature DB >> 23939889

In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method.

María Díez-Aguilar1, María-Isabel Morosini, Rosa del Campo, María García-Castillo, Javier Zamora, Rafael Cantón.   

Abstract

The broth microdilution method for fosfomycin and Pseudomonas aeruginosa was assessed and compared with the approved agar dilution method in 206 genetically unrelated P. aeruginosa clinical isolates. Essential agreement between the two methods was 84%, and categorical agreement was 89.3%. Additionally, Etest and disk diffusion assays were performed. Results validate broth microdilution as a reliable susceptibility testing method for fosfomycin against P. aeruginosa. Conversely, unacceptable concordance was established between Etest and disk diffusion results with agar dilution results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23939889      PMCID: PMC3811245          DOI: 10.1128/AAC.00589-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

Authors:  M de Cueto; L López; J R Hernández; C Morillo; A Pascual
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae.

Authors:  Lorena López-Cerero; Marina de Cueto; Miguel Angel Díaz-Guerrero; Concepción Morillo; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2007-02-08       Impact factor: 5.790

3.  Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.

Authors:  Ching-Lan Lu; Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Lee-Jene Teng; John D Turnidge; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

Review 4.  The revival of fosfomycin.

Authors:  Argyris S Michalopoulos; Ioannis G Livaditis; Vassilios Gougoutas
Journal:  Int J Infect Dis       Date:  2011-09-25       Impact factor: 3.623

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.

Authors:  María García-Castillo; Rosa Del Campo; María Isabel Morosini; Elena Riera; Gabriel Cabot; Rob Willems; Rosa van Mansfeld; Antonio Oliver; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

Review 8.  Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.

Authors:  Matthew E Falagas; Antonia C Kastoris; Drosos E Karageorgopoulos; Petros I Rafailidis
Journal:  Int J Antimicrob Agents       Date:  2009-04-28       Impact factor: 5.283

9.  The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.

Authors:  Alfredo Castañeda-García; Alexandro Rodríguez-Rojas; Javier R Guelfo; Jesús Blázquez
Journal:  J Bacteriol       Date:  2009-09-04       Impact factor: 3.490

Review 10.  Pseudomonas aeruginosa - a phenomenon of bacterial resistance.

Authors:  Tanya Strateva; Daniel Yordanov
Journal:  J Med Microbiol       Date:  2009-06-15       Impact factor: 2.472

View more
  10 in total

1.  Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.

Authors:  María Díez-Aguilar; María Isabel Morosini; Emin Köksal; Antonio Oliver; Miquel Ekkelenkamp; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 2.  Fosfomycin: Resurgence of an old companion.

Authors:  Sangeeta Sastry; Yohei Doi
Journal:  J Infect Chemother       Date:  2016-02-28       Impact factor: 2.211

3.  Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.

Authors:  Elizabeth C Smith; Hunter V Brigman; Jadyn C Anderson; Christopher L Emery; Tiffany E Bias; Phillip J Bergen; Cornelia B Landersdorfer; Elizabeth B Hirsch
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

Review 4.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 5.  Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales.

Authors:  Dina Zheng; Phillip J Bergen; Cornelia B Landersdorfer; Elizabeth B Hirsch
Journal:  Antimicrob Agents Chemother       Date:  2021-11-22       Impact factor: 5.938

6.  Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.

Authors:  L V Perdigão-Neto; M S Oliveira; C F Rizek; C M D M Carrilho; S F Costa; A S Levin
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

7.  Is a New Standard Needed for Diffusion Methods for In Vitro Susceptibility Testing of Fosfomycin against Pseudomonas aeruginosa?

Authors:  María Díez-Aguilar; Laura Martínez-García; Rafael Cantón; María Isabel Morosini
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

8.  Genome-Wide Identification of Antimicrobial Intrinsic Resistance Determinants in Staphylococcus aureus.

Authors:  Martin Vestergaard; Bingfeng Leng; Jakob Haaber; Martin S Bojer; Christina S Vegge; Hanne Ingmer
Journal:  Front Microbiol       Date:  2016-12-19       Impact factor: 5.640

9.  In Vitro Activity of Newer and Conventional Antimicrobial Agents, Including Fosfomycin and Colistin, against Selected Gram-Negative Bacilli in Kuwait.

Authors:  Wadha Alfouzan; Rita Dhar; David P Nicolau
Journal:  Pathogens       Date:  2018-09-17

10.  In vitro efficacy of vancomycin combined with fosfomycin against Vancomycin-Resistant Enterococci strains.

Authors:  Gulseren Aktas
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.